Lombard Odier Asset Management (USA)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,398
Closed -$1.22M 159
2026
Q1
$1.22M Sell
19,398
-2,710
-12% -$217K 0.13% 98
2025
Q4
$2.11M Sell
22,108
-5,716
-21% -$560K 0.2% 74
2025
Q3
$2.72M Buy
+27,824
New +$2.88M 0.18% 89
2018
Q3
Sell
-7,500
Closed -$245K 237
2018
Q2
$245K Buy
+7,500
New +$226K 0.02% 249
2016
Q4
Sell
-20,000
Closed -$476K 176
2016
Q3
$476K Buy
+20,000
New +$477K 0.04% 224

Other funds holding BSX

Lombard Odier Asset Management (USA)'s BSX Position: Q2 2026 in Review

Lombard Odier Asset Management (USA) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 19,398 shares — an estimated $1.22M sold.

Lombard Odier Asset Management (USA) first reported a position in BSX in Q3 2016 and held it in 5 quarters. The position peaked at $2.72M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Lombard Odier Asset Management (USA) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 19,398 Boston Scientific shares in Q2 2026, an estimated $1.22M.
  • Lombard Odier Asset Management (USA) first reported a position in Boston Scientific in Q3 2016 and held it in 5 quarters.
  • Lombard Odier Asset Management (USA)'s Boston Scientific position peaked at $2.72M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2026, filed 14 Aug 2026.